These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 19004730

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. International Conference on Harmonisation; Guidance on E15 Pharmacogenomics Definitions and Sample Coding; Availability. Notice.
    Food and Drug Administration, HHS.
    Fed Regist; 2008 Apr 08; 73(68):19074-6. PubMed ID: 18677821
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 3rd EORTC-NCI International Meeting on Cancer Molecular Markers: From Discovery to Clinical Practice.
    Taube SE, Gion M, Schilsky RL.
    Expert Rev Mol Diagn; 2004 Jul 08; 4(4):431-3. PubMed ID: 15225090
    [No Abstract] [Full Text] [Related]

  • 9. Personalized-medicine trials on the rise.
    Benowitz S.
    J Natl Cancer Inst; 2012 Oct 03; 104(19):1425-6. PubMed ID: 23008496
    [No Abstract] [Full Text] [Related]

  • 10. From genomic landscapes to personalized cancer management-is there a roadmap?
    Swanton C, Caldas C.
    Ann N Y Acad Sci; 2010 Oct 03; 1210():34-44. PubMed ID: 20973797
    [Abstract] [Full Text] [Related]

  • 11. Using biomarkers in drug development.
    Workman P.
    Clin Adv Hematol Oncol; 2006 Oct 03; 4(10):736-9. PubMed ID: 17099630
    [No Abstract] [Full Text] [Related]

  • 12. [Use of molecular genetic analysis in selecting antitumor therapy].
    Imianitov EN, Moiseenko VM.
    Vopr Onkol; 2008 Oct 03; 54(2):121-32. PubMed ID: 18522159
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The search for optimal response prediction in cancer leads to a personalized approach.
    Van Cutsem E, Ciardiello F.
    Target Oncol; 2010 Mar 03; 5(1):3-4. PubMed ID: 20349283
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biomarkers of clinical trials using molecular inhibitors and radiotherapy: state-of-the-art. Preface.
    Bristow RG.
    Cancer Metastasis Rev; 2008 Sep 03; 27(3):337-8. PubMed ID: 18427733
    [No Abstract] [Full Text] [Related]

  • 20. Rational combinations using HDAC inhibitors.
    Bots M, Johnstone RW.
    Clin Cancer Res; 2009 Jun 15; 15(12):3970-7. PubMed ID: 19509171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.